List of Tables
    Table 1. Tenofovir Disoproxil Fumarate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Tenofovir Disoproxil Fumarate Market Trends
    Table 3. Tenofovir Disoproxil Fumarate Market Drivers
    Table 4. Tenofovir Disoproxil Fumarate Market Challenges
    Table 5. Tenofovir Disoproxil Fumarate Market Restraints
    Table 6. Global Tenofovir Disoproxil Fumarate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tenofovir Disoproxil Fumarate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tenofovir Disoproxil Fumarate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tenofovir Disoproxil Fumarate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tenofovir Disoproxil Fumarate Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tenofovir Disoproxil Fumarate Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Tenofovir Disoproxil Fumarate Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Tenofovir Disoproxil Fumarate Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Tenofovir Disoproxil Fumarate Sales Share by Manufacturer, 2017-2022
    Table 15. Global Tenofovir Disoproxil Fumarate Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Tenofovir Disoproxil Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Tenofovir Disoproxil Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate as of 2021)
    Table 18. Top Players of Tenofovir Disoproxil Fumarate in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Tenofovir Disoproxil Fumarate Product Type
    Table 20. Date of International Manufacturers Enter into Tenofovir Disoproxil Fumarate Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Tenofovir Disoproxil Fumarate Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Tenofovir Disoproxil Fumarate Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Tenofovir Disoproxil Fumarate Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Tenofovir Disoproxil Fumarate Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Tenofovir Disoproxil Fumarate Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Tenofovir Disoproxil Fumarate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Tenofovir Disoproxil Fumarate Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Tenofovir Disoproxil Fumarate Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Tenofovir Disoproxil Fumarate Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Tenofovir Disoproxil Fumarate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Tenofovir Disoproxil Fumarate Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Tenofovir Disoproxil Fumarate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Tenofovir Disoproxil Fumarate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Glaxo SmithKline Corporation Information
    Table 43. Glaxo SmithKline Description and Business Overview
    Table 44. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product
    Table 46. Glaxo SmithKline Recent Development
    Table 47. Gilead PHARMACARE Corporation Information
    Table 48. Gilead PHARMACARE Description and Business Overview
    Table 49. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Gilead PHARMACARE Product
    Table 51. Gilead PHARMACARE Recent Development
    Table 52. Chengdu Brilliant Pharmaceutical Corporation Information
    Table 53. Chengdu Brilliant Pharmaceutical Description and Business Overview
    Table 54. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Chengdu Brilliant Pharmaceutical Product
    Table 56. Chengdu Brilliant Pharmaceutical Recent Development
    Table 57. CHIA TAI TIANQING (CTTQ) Pharmaceutical Corporation Information
    Table 58. CHIA TAI TIANQING (CTTQ) Pharmaceutical Description and Business Overview
    Table 59. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. CHIA TAI TIANQING (CTTQ) Pharmaceutical Product
    Table 61. CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development
    Table 62. Anhui Biochem Pharmaceutical Corporation Information
    Table 63. Anhui Biochem Pharmaceutical Description and Business Overview
    Table 64. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Anhui Biochem Pharmaceutical Product
    Table 66. Anhui Biochem Pharmaceutical Recent Development
    Table 67. Qilu Pharmaceutical Corporation Information
    Table 68. Qilu Pharmaceutical Description and Business Overview
    Table 69. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Qilu Pharmaceutical Product
    Table 71. Qilu Pharmaceutical Recent Development
    Table 72. Cipla Corporation Information
    Table 73. Cipla Description and Business Overview
    Table 74. Cipla Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Cipla Product
    Table 76. Cipla Recent Development
    Table 77. Zydus Cadila Corporation Information
    Table 78. Zydus Cadila Description and Business Overview
    Table 79. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Zydus Cadila Product
    Table 81. Zydus Cadila Recent Development
    Table 82. Dr Reddy's Laboratories Corporation Information
    Table 83. Dr Reddy's Laboratories Description and Business Overview
    Table 84. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Dr Reddy's Laboratories Product
    Table 86. Dr Reddy's Laboratories Recent Development
    Table 87. Mylan Pharmaceuticals Corporation Information
    Table 88. Mylan Pharmaceuticals Description and Business Overview
    Table 89. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Mylan Pharmaceuticals Product
    Table 91. Mylan Pharmaceuticals Recent Development
    Table 92. Natco Pharma Corporation Information
    Table 93. Natco Pharma Description and Business Overview
    Table 94. Natco Pharma Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Natco Pharma Product
    Table 96. Natco Pharma Recent Development
    Table 97. Emcure Pharmaceuticals Corporation Information
    Table 98. Emcure Pharmaceuticals Description and Business Overview
    Table 99. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Emcure Pharmaceuticals Product
    Table 101. Emcure Pharmaceuticals Recent Development
    Table 102. Torrent Pharmaceuticals Corporation Information
    Table 103. Torrent Pharmaceuticals Description and Business Overview
    Table 104. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Torrent Pharmaceuticals Product
    Table 106. Torrent Pharmaceuticals Recent Development
    Table 107. Wockhardt Ltd Corporation Information
    Table 108. Wockhardt Ltd Description and Business Overview
    Table 109. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Wockhardt Ltd Product
    Table 111. Wockhardt Ltd Recent Development
    Table 112. Hetero Drugs Corporation Information
    Table 113. Hetero Drugs Description and Business Overview
    Table 114. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Hetero Drugs Product
    Table 116. Hetero Drugs Recent Development
    Table 117. Abbott Corporation Information
    Table 118. Abbott Description and Business Overview
    Table 119. Abbott Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Abbott Product
    Table 121. Abbott Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Tenofovir Disoproxil Fumarate Customers List
    Table 125. Tenofovir Disoproxil Fumarate Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tenofovir Disoproxil Fumarate Product Picture
    Figure 2. Global Tenofovir Disoproxil Fumarate Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tenofovir Disoproxil Fumarate Market Size 2017-2028 (US$ Million)
    Figure 4. Global Tenofovir Disoproxil Fumarate Sales 2017-2028 (K Pcs)
    Figure 5. United States Tenofovir Disoproxil Fumarate Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Tenofovir Disoproxil Fumarate Market Size 2017-2028 (US$ Million)
    Figure 7. United States Tenofovir Disoproxil Fumarate Sales 2017-2028 (K Pcs)
    Figure 8. United States Tenofovir Disoproxil Fumarate Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Tenofovir Disoproxil Fumarate Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Tenofovir Disoproxil Fumarate Report Years Considered
    Figure 11. Product Picture of 30 Pcs/Box
    Figure 12. Product Picture of 10 Pcs/Box
    Figure 13. Global Tenofovir Disoproxil Fumarate Market Share by Type in 2022 & 2028
    Figure 14. Global Tenofovir Disoproxil Fumarate Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Tenofovir Disoproxil Fumarate Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Tenofovir Disoproxil Fumarate Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Tenofovir Disoproxil Fumarate Market Share by Type in 2022 & 2028
    Figure 20. United States Tenofovir Disoproxil Fumarate Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Tenofovir Disoproxil Fumarate Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Tenofovir Disoproxil Fumarate Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of HIV-1 Infection
    Figure 26. Product Picture of Chronic Hepatitis
    Figure 27. Product Picture of Other
    Figure 28. Global Tenofovir Disoproxil Fumarate Market Share by Application in 2022 & 2028
    Figure 29. Global Tenofovir Disoproxil Fumarate Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Tenofovir Disoproxil Fumarate Sales by Application (2017-2028) & (K Pcs)
    Figure 32. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Tenofovir Disoproxil Fumarate Price by Application (2017-2028) & (USD/Pcs)
    Figure 34. United States Tenofovir Disoproxil Fumarate Market Share by Application in 2022 & 2028
    Figure 35. United States Tenofovir Disoproxil Fumarate Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Tenofovir Disoproxil Fumarate Sales by Application (2017-2028) & (K Pcs)
    Figure 38. United States Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Tenofovir Disoproxil Fumarate Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. North America Tenofovir Disoproxil Fumarate Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 41. North America Tenofovir Disoproxil Fumarate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Tenofovir Disoproxil Fumarate Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 45. Europe Tenofovir Disoproxil Fumarate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Tenofovir Disoproxil Fumarate Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 64. Latin America Tenofovir Disoproxil Fumarate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Tenofovir Disoproxil Fumarate Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Middle East & Africa Tenofovir Disoproxil Fumarate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Tenofovir Disoproxil Fumarate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Tenofovir Disoproxil Fumarate Value Chain
    Figure 74. Tenofovir Disoproxil Fumarate Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed